Clinical Trial Update: Interleukin-2 Therapy for HIV Infection - Supplemental Procedures [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update of Interleukin-2 therapy for HIV infection with supplemental procedures; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infection

Drugs mentioned

• Interleukin-2 (interleukin-2)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Acquired Immunodeficiency Syndrome, HIV Infection | Phase 2 | Status: COMPLETED